SCHEMBL265509

SCHEMBL265509

C/C=C(\F)C(=O)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3439196 1.00
Pentachlorophenol SCHEMBL10921533 0.83 GPR35 (0.37)
SCHEMBL8121882 0.83
SCHEMBL12743046 0.83
SCHEMBL8121880 0.83
SCHEMBL24461710 0.82 ALDH1A1 (0.44)
SCHEMBL30558699 0.81
SCHEMBL29194429 0.81 NPSR1 (0.43)
SCHEMBL29832048 0.81 NPSR1 (0.43)
SCHEMBL27499186 0.81 NPSR1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262842-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME LLC 2024-08-08 US disclosed
EP-4329749-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT Merck Sharp & Dohme LLC (US) 2024-03-06 EP disclosed
WO-2022232318-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME CORP. (US) 2022-11-03 WO disclosed
US-8629126-B2 Quinolone derivative or pharmaceutically acceptable salt thereof ASTELLAS PHARMA INC. (JP) 2014-01-14 US disclosed
US-8629126-B2 Quinolone derivative or pharmaceutically acceptable salt thereof ASTELLAS PHARMA INC. (JP) 2014-01-14 US disclosed
US-20120136025-A1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC. (JP) 2012-05-31 US disclosed
US-20120136025-A1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC. (JP) 2012-05-31 US disclosed
US-8133882-B2 Quinolone derivative or pharmaceutically acceptable salt thereof ASTELLAS PHARMA INC (JP) 2012-03-13 US disclosed
US-8133882-B2 Quinolone derivative or pharmaceutically acceptable salt thereof ASTELLAS PHARMA INC (JP) 2012-03-13 US disclosed
EP-1995240-B1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-02-22 EP disclosed
US-20020156053-A1 New aminopropylphosphinic acids GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT 2002-10-24 US disclosed
EP-1239843-A1 NEW (AMINOPROPYL)METHYLPHOSPHINIC ACIDS AstraZeneca AB (SE) 2002-09-18 EP disclosed
WO-2001041743-A1 NEW (AMINOPROPYL)METHYLPHOSPHINIC ACIDS ASTRAZENECA AB (SE) 2001-06-14 WO disclosed
US-5459149-A Penta-2,4-dienamides and use as pesticides ROUSSEL UCLAF (FR) 1995-10-17 US disclosed
US-5270343-A Penta-2,4-dienamides and use as pesticides ROUSSEL UCLAF (FR) 1993-12-14 US disclosed
CN-1073674-A Sterilant ROUSSEL UCLAF (FR) 1993-06-30 CN disclosed
EP-0202500-B1 NOVEL CARBOXYLIC ACID ESTERS, METHODS FOR PRODUCTION THEREOF AND INSECTICIDES CONTAINING THEM AS THE ACTIVE INGREDIENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-02-22 EP disclosed
US-4774369-A ALCOHOLS AS INTERMEDIATES FOR INSECTICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-09-27 US disclosed
US-4714712-A Carboxylic acid esters and insecticides containing them as the active ingredient SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-12-22 US disclosed
EP-0202500-A1 Novel carboxylic acid esters, methods for production thereof and insecticides containing them as the active ingredient SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-11-26 EP disclosed